S6 Ep38: FDA Approval Insights: Pacritinib in Myelofibrosis

Dr Mesa discusses the data that led to the FDA approval of pacritinib, toxicities clinicians should be aware of when prescribing the JAK inhibitor, and the next steps for pacritinib in the space.